|
A4 is unknown.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by abiomed inc or its employees that the report constitutes an admission that the product, abiomed inc, or its employees, caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
An impella cp device was inserted into the right femoral artery in a 89-year-old female patient presenting in acute myocardial infarction (ami) and cardiogenic shock (cgs), in scai stage e shock, and on a ventilator for respiratory support, prior to initiation of support.The impella was inserted for ventricular support for a protected percutaneous coronary intervention (pci).While the patient was in the intensive care unit (icu), there was a loss of impella in aorta (ao) and left ventricle (lv) signals on the automated impella controller (aic).Flow were at 3.5l/min, the motor current was pulsatile, and the dial was still turning on the aic.To troubleshoot, the nurse pushed the white connector into the aic and waveform signals returned.No further issues were noted.There was no noted interruption of flow or support for the patient.The following day after impella support, the family withdrew care due to the patient requiring continuous renal replacement therapy (crrt), and the patient expired on support.The impella functioned at p-6 at 2.9l/min as intended.Renal failure is a known adverse event associated with impella's mechanical support.The impella is conservatively being reported for death; however, is unlikely to have contributed to the patient's death, which was most likely due to the clinical condition of a critically ill patient in acute myocardial infarction and cardiogenic shock, complicated by stage e shock.
|